manufacturer ended production 2014 drug not making money industry similar moves including behringwerke wyeth pharmaceuticals pfizer treatment situation dire doctors borders describes snakebites world neglected public health emergencies october dozens experts 18th world congress international society toxinology oxford england called world health organization relist snakebite neglected tropical disease bites occur africa southeast asia antivenom development stuck 19th century field underfunded says david williams clinical toxinologist herpetologist heads australian venom research unit university melbourne ceo australian nonprofit global snakebite initiative isolate compounds treatment researchers typically inject subtoxic levels venom animals collect antibodies formed immune response purify result antivenom tailored array toxins